Behind the science  of genetics/of HIV/of vaccines/of asthma/of cancer/of medicines/of lupus/of adjuvants/of AMR/of GSK

Innovation stories from GSK

Behind the science of genetics/of HIV/of vaccines/of asthma/of cancer/of medicines/of lupus/of adjuvants/of AMR/of GSK

Innovation stories from GSK

Editorial

Digital twin: using advanced technology to accelerate vaccine development

3 min read time

Lab worker adjusting glasses
Editorial

The ‘tripledemic’ will hit older people hard this winter – but there are things we can all do to reduce the impact

4 min read time

GSK lungs illustration
Editorial

‘The roar I hear is the next stage of the rocket firing’: MAPS technology and the new age of vaccine development

5 min read time

Vaccine Manufacturing Production Line
Editorial

‘It’s insidious and it’s getting worse’: AMR and the urgent need for novel antibiotics

5 min read time

AMR Image
Editorial

‘We’re not a world of men – it's as simple as that’: how gender diversity in clinical trials improves health outcomes for women

5 min read time

Early talent in a lab
Editorial

‘I had never experienced anything like it’: the pain, risks, and first symptoms of shingles every adult should know

3 min read time

GSK Herpes Zoster Virus illustration
Filter search

Filter search

Reset all filters
GSK manufacturing facility in Wavre
Editorial
'Prevention is the best medicine to stop disease before it starts'
GSK Team - 3 min read time
GSK Oncology T-cell therapy research
Editorial
Biomarker testing is helping doctors find precision treatments for patients that could dramatically improve health outcomes
5 min read time
Lab work
Editorial
Harnessing tumour DNA to detect cancer recurrence earlier
3 min read time
Red blood cells
Editorial
Using new science to get ahead of myelofibrosis - a rare blood cancer
2 min read time
Nextgen Header
Editorial
How the next generation of immuno-oncology could help us get ahead of cancer
2 min read time
Scientist inspecting vial
Q&A
1.4 million reasons to get ahead of gynaecologic cancers
2 min read time
R&D scientific test
Editorial
Synthetic Lethality: accelerating precision cancer treatments
5 min read time
R&D scientist in high throughput screening lab.
Q&A
How we're getting ahead of an incurable blood cancer
3 min read time

Continue to Company